Based in Cambridge, MA, the role is a research leader in the area of Gastroenterological (GI) Disease with a focus on microbiome research and external innovation. Responsible for identifying opportunities within local, national and international centers of excellence for novel microbiome-related approaches to the treatment of GI disorders. Leads research projects in collaboration with external partners.
- As a scientific research leader within the Gastrointestinal Drug Discovery Unit, will be working within a highly matrixed & virtual environment, contributes to building a robust preclinical and early clinical pipeline in gastroenterological diseases.
- Plays a key role in translational research activities in partnership with Translational Research & Early Clinical research team and expert external groups
- Identifies, establishes and ensures the success of key external collaborations targeting and developing novel microbiome therapeutic approaches to GI disorders
- Collaborates, influences and leads cross-functional matrix teams from Research, the GI Therapeutic Area Unit, Legal, Business Development, etc.
- Builds relationships & collaborates with scientific leaders, KOLs, academic partners, CROs and biotech companies and is seen as an international subject matter expert in GI microbiome research and therapeutics.
- Responsible for oversight of local external partnerships (CRO, biotech partners, academic labs, etc.) to ensure milestones, deliverables are met according to timelines and expectations of quality.
- Seeks and proposes preclinical and clinical in licensing candidates and provides expert input to their evaluation
- Is a member of the GI matrix team and contributes to strategic decisions to advance research projects from early stages to developmental stages in a way that maximizes the likelihood of long term success (POC and beyond).
- Is an active member of the GI DDU leadership team, supporting the Head GI DDU to make the best use of human and financial resources.
- Identified as a Global Takeda thought leader in microbiome and GI disease research and provides subject-matter expertise.
- Represents Takeda and is responsible for creating a presence in GI microbiota research and related scientific community through scientific meetings, advisory boards, online research communities, etc..
- Keeps up with the up-to-date scientific advancement (e.g. competitive situation, new technology, new research portfolio, and new partnership) and is well informed about current regulatory (FDA, EMA, etc.) requirements and trends.
- Has an advanced degree in health or life sciences (e.g., Ph.D., M.D., D.V.M.) with proven GI microbiome research experience and accomplishment.
- Is highly knowledgeable and experienced in aspects of microbiome research in context of GI motility and functional bowel disorders, immunology and inflammatory bowel diseases and/or liver diseases
- Demonstrates good knowledge of drug discovery and translational research, through to early clinical research (Proof of Concept). Industry experience would be an advantage.
- Has strong leadership skills and acumen.
- Has excellent written and verbal communication skills in English.
- Capable of leading a matrixed team comprised of scientists from within Takeda as well as external collaborators.
- Requires approximately 20% or more travel, including international.
we are driven to improve people's lives
Takeda is an EEO employer of minorities, women, disabled, protected veterans. For more information, visithttp://www.takeda.us/careers/EEO_Policy_Statement.aspx
No Phone Calls or Recruiters Please.